首页|Na?ve and in vitro -activated primary mouse CD8 + T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering

Na?ve and in vitro -activated primary mouse CD8 + T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering

Yerly Laura Abe Jun Pfenninger Petra

DOI：10.1101/2021.09.14.460345

来源：

bioRxiv

Na?ve and in vitro -activated primary mouse CD8 + T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering

Yerly Laura ¹Abe Jun ¹Pfenninger Petra¹

作者信息

1. Department of Oncology, Microbiology and Immunology, University of Fribourg
折叠

引用本文复制引用

Yerly Laura,Abe Jun,Pfenninger Petra.Na?ve and in vitro -activated primary mouse CD8 + T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering[EB/OL].(2025-03-28)[2025-11-28].https://www.biorxiv.org/content/10.1101/2021.09.14.460345.

学科分类

生物科学研究方法、生物科学研究技术/基础医学/分子生物学

首发时间： 2025-03-28

下载量：0

点击量：217

段落导航

Na?ve and in vitro -activated primary mouse CD8 + T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering

Na?ve and in vitro -activated primary mouse CD8 + T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering

引用本文复制引用

学科分类

评论